Critical Reviews in Oncology / Hematology
Volume 61, Issue 1 , Pages 26-43, January 2007

Facilitating cells: Novel promoters of stem cell alloengraftment and donor-specific transplantation tolerance in the absence of GVHD

  • Yolonda L. Colson

      Affiliations

    • From the Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, United States
  • ,
  • Vivek R. Shinde Patil

      Affiliations

    • From the Division of Thoracic Surgery, Department of Surgery, Brigham and Women's Hospital, Boston, MA 02115, United States
  • ,
  • Suzanne T. Ildstad

      Affiliations

    • Institute for Cellular Therapeutics, Baxter Biomedical Research Building, University of Louisville, 570 South Preston Street, Suite 404, Louisville, KY 40202, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 502 852 2080; fax: +1 502 852 2079.

Accepted 16 June 2006.

Abstract 

Bone marrow transplantation (BMT) is the treatment of choice for many hematological malignancies and immunopathologies. Unfortunately, success is often impeded by engraftment failure and graft-versus-host disease (GVHD). A rare bone marrow population known as the facilitating cell (FC) has been identified which facilitates stem cell engraftment and circumvents these obstacles in murine experimental models. This review discusses the identification and characterization of this rare population and provides an emerging portrait of FC origin, ontogeny and function. The promotion of durable stem cell engraftment in MHC disparate recipients, GVHD inhibition and tolerance induction by the FC suggests that future therapies in hematopoietic cell transplantation and tolerance induction for solid organ transplants may be significantly improved through the application of FC transplantation.

Keywords: Facilitating cell, Bone marrow transplantation, GVHD, Engraftment, Tolerance

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1040-8428(06)00120-X

doi:10.1016/j.critrevonc.2006.06.011

Critical Reviews in Oncology / Hematology
Volume 61, Issue 1 , Pages 26-43, January 2007